Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Fierce Pharma
US reveals new Medicare prices for second round of IRA drugs
The U.S. has revealed price reductions for 15 prescription drugs negotiated by Medicare through the IRA, headlined by Novo Nordisk's semaglutide.
Kevin Dunleavy
Nov 26, 2025 11:42am
Dr. Oz vows to sell healthcare stocks once confirmed to run CMS
Feb 19, 2025 7:30pm
Bristol Myers Squibb latest to roll out 340B restrictions
Jan 19, 2022 9:30am
AbbVie latest to impose 340B sales restrictions
Jan 5, 2022 9:30am
House Dems: 14 drugmakers spent $577B on buybacks, dividends
Jul 9, 2021 7:05am
Healthcare stocks rise following midterm election—roundup
Nov 9, 2018 12:05am
